Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Centene (CNC) is showing tangible margin recovery backed by outsized free cash flow, a cheap valuation (EV/EBITDA ~5.3, P/FCF ~3.6) and a management focus on profitability. This trade idea outlines a tactical long with entry, stop and targets and explains the key catalysts and risks investors should watch over the next 180 trading days.
Broadcom (AVGO) looks expensive on headline multiples, but the market is conflating near-term macro noise with structural strength in semiconductors and infrastructure software. At $368.45 we see an asymmetric trade: durable free cash flow of $32.8B, industry-leading margins and customer stickiness create a path to low-double-digit upside while dow…
Neurocrine (NBIX) offers a pragmatic entry after recent weakness: established cash-generative franchises, a recent rare-disease acquisition, and an active clinical calendar create multiple value drivers. The technicals are beatable and the balance sheet supports near-term dealmaking and buybacks. Trade plan targets a mid-term rebound while limiting…
We upgrade General Dynamics (GD) to Buy. The stock trades at roughly 23x earnings and 16x free cash flow - levels that understate the company's cash generation, low leverage and government-driven backlog growth. Combine that with recent industry financing initiatives and large shipbuilding awards, and the risk/reward favors a mid-term long trade wi…
KORU Medical (KRMD) has fallen back to near-term support after a multi-month downtrend, leaving the shares oversold and cheap relative to recent upside expectations. The company has a working infusion-delivery platform, modest leverage, and a history of revenue beats. This trade idea lays out an actionable long-swing entry at $3.20 with a $4.50 tar…
SuperiorMed Holdings Limited, a Cayman Islands-based healthcare management platform focused on longevity medicine, wellness services, and health tourism in the UAE, has entered into a merger agreement with Starry Sea Acquisition Corp (Nasdaq: SSEA), a Cayman Islands special purpose acquisition company (SPAC). Upon closing, the combined entity will …
Citi strategists interpret the recent joint market intervention by the United States and Japan as evidence of an informal currency cooperation that connects foreign-exchange policy with wider economic and national-security ties. The bank frames the move as coordinated policy action - not a monetary union - and notes it may bolster Japan's $550 bill…
Equifax is trading like a mature credit-data vendor, yet its recurring identity and workforce businesses, strong free cash flow, and secular tailwinds in identity verification argue for a higher multiple. This trade idea takes a constructive long stance with clearly defined entry, stop and target levels and a 180-trading-day horizon.
Medtronic (MDT) trades at roughly $93 and appears materially mispriced vs. peers if its CAS (advanced surgical automation/robotics) rollout gains traction. With a $119B market cap, healthy FCF ($5.43B), a 3.1% dividend yield, and manageable leverage (debt/equity ~0.57), the balance sheet supports a buy-and-hold into execution. Entry $93.00, stop $8…
President Donald Trump said Tehran was not prepared to accept what he called the "right deal" and indicated U.S. forces were watching developments. Washington has pledged what it described as the toughest financial penalties in history targeting Iran’s leadership, with Treasury Secretary Scott Bessent set to outline details on Monday. Meanwhile, di…
Trade officials from the United States and Canada are engaged in intensive negotiations to establish a framework for steel and aluminum imports ahead of an impending midnight deadline. The discussion centers on implementing tariff-rate quotas that would apply a 25% levy on a portion of shipments while maintaining a 50% duty on volumes exceeding agr…
Brandywine Realty Trust announced the expiration of its tender offer for up to $50 million of its outstanding 7.550% guaranteed 2028 Notes, with approximately 93.5% of the notes tendered but only $50 million accepted due to proration. The tender offer for the 2029 Notes remains open with an increased acceptance cap. The company plans to fund these …
Eli Lilly is trading with strong momentum after robust GLP-1 sales and pipeline news, but new oral pills from competitors could create headline-driven volatility. We propose a mid-term long on LLY with a defined entry, stop and target while outlining catalysts and risks tied to competition from Novo Nordisk and others.
Ocean Power Technologies, Inc. disclosed that its independent auditor included a going concern qualification in the audit report of its 2026 Annual Report. This highlights uncertainties about the company's ability to continue operations without additional financing. The company provides maritime infrastructure solutions including clean power and au…
Evercore (EVR) looks positioned to benefit from elevated M&A activity through 2027. Strong free cash flow, a sub-15x P/E on documented EPS, and a capital-light balance sheet support a constructive trade. Technicals show recent weakness, offering a disciplined entry for a long-term trade into year-end.
Taylor Devices reported a weak quarter that disappointed the market, yet the company's pristine balance sheet, positive cash flow and accelerating technicals create a compelling risk/reward for a mid-term long trade. Entry at today's price captures momentum while a tight stop limits downside; target reflects a retest of higher multi-month resistanc…
Moody's has affirmed multiple credit ratings for TTM Technologies and shifted the company's outlook from stable to positive, citing stronger revenue and profit performance driven by AI-related data center demand and sustained aerospace and defense activity. The rating agency highlighted improved scale and diversification following recent acquisitio…
S&P Global Ratings has affirmed Kenya's long- and short-term foreign and local currency sovereign credit ratings at 'B/B' and left the outlook at stable, while keeping the transfer and convertibility assessment at 'B+'. The rating agency balances prospects for continued robust growth and access to concessional financing against elevated interest co…
Shares listed on Moscow ended the session in positive territory as the MOEX Russia Index rose 0.60%. Outperformance came from mining and metals names, while select banking and telecom issues lagged. Volatility on MOEX options declined and commodity prices showed mixed moves, with gold jumping sharply.
SolarMax Technology, Inc., a Nasdaq-listed solar energy company, announced it received a Nasdaq notice for failing to file its Form 10-Q for the quarter ended June 30, 2026. The company has until October 19, 2026, to submit a plan to regain compliance and may be granted an extension up to February 16, 2027 if accepted. SolarMax focuses on solar and…
ProQR is a clinical-stage RNA therapeutics company centered on its Axiomer ADAR-mediated RNA editing platform. With a market cap near $322M, a runway into mid-2027, and multiple anticipated clinical and corporate milestones, PRQR is a high-risk/high-reward buy. Entry near $2.34, stop at $1.60, primary target $4.50 (long-term), with an intermediate …
Flowers Foods (FLO) looks oversold relative to its cash-flow profile. At roughly $7 a share, the company trades with an enterprise value of ~$3.22B and generated about $296M in free cash flow, implying a low multiple and a material upside if volumes stabilize and the dividend reset funds deleveraging. This is a mid-term (45 trading days) trade idea…
Comscore, Inc. announced employment inducement grants to new employee Aaron Doades, comprising restricted stock units and stock options that vest over a multi-year period as per Nasdaq Listing Rule 5635(c)(4).
Cytek Biosciences announced a jury verdict in a patent infringement case brought by Beckman Coulter, with the jury ruling in Cytek’s favor on three out of four claims, finding noninfringement or invalidity. However, for one claim, the jury found infringement under the doctrine of equivalents and awarded $56 million in damages. Cytek plans to challe…
Valor Gold looks fairly priced today for a junior gold explorer. The company has promising geology but needs time, financing and positive drill results to shift the market's view. This trade is a cautious long with a long-term horizon and tight risk controls.
